List of works - Laura Zanotti

A Phase II study of olaparib in breast cancer patients: biological evaluation from a 'window of opportunity' trial

scientific article published on 21 June 2016

A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-Negative Breast Cancers

scientific article

Altered immunolocalization of heat-shock proteins in human peri-implant gingiva

scientific article published on 22 January 2007

Apatinib for the treatment of gastric cancer

scientific article published on 15 July 2016

Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?

scientific article published on 8 April 2017

Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.

scientific article published on 26 August 2015

CDK4/6 inhibitors in HER2-positive breast cancer

scientific article published on 24 February 2017

Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis

scientific article published on 01 September 2013

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

scientific article

Diagnostic tests based on gene expression profile in breast cancer: from background to clinical use.

scientific article

Effect of Primary Letrozole Treatment on Tumor Expression of mTOR and HIF-1α and Relation to Clinical Response

scientific article

Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma

scientific article

Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery

scientific article published on 21 September 2015

Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy

scientific article

HE4 and epithelial ovarian cancer: comparison and clinical evaluation of two immunoassays and a combination algorithm

scientific article published on 30 April 2011

HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study

scientific article

Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome

scientific article published on 01 December 2012

Human kallikrein 5: an interesting novel biomarker in ovarian cancer patients that elicits humoral response

scientific article published in August 2009

Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues

scientific article

Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunity.

scientific article published on 30 April 2015

Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials

scientific article published on 27 February 2016

Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma

scientific article published on 28 January 2013

Low-Dose Oral Ethinylestradiol With Concomitant Low-Dose Acetylsalicylic Acid for Advanced Castrate-Resistant Prostate Cancer

scientific article

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis

scientific article

Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy ⬇️

scientific article published on June 27, 2013

Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence

scientific article published on 27 July 2009

MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities.

scientific article published on 13 June 2013

Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition

scientific article published on 10 October 2016

Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?

scientific article

New molecular therapies in patients with advanced Hepatocellular Cancer in second line of treatment: Is a real defeat?: Results from a literature based meta-analysis of randomized trials

scientific article published on 29 October 2016

No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell Lung Cancer: A Literature-Based Meta-Analysis of Randomized Trials.

scientific article

Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials

scientific article

Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis

scientific article published on 02 July 2013

Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management

scientific article published on 25 October 2011

Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer: A meta-analysis of randomized trials

scientific article

Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients

scientific article

Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma

scientific article

Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility.

scientific article published on April 2017

Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy

scientific article published on 17 October 2019

List of works by Laura Zanotti

A Phase II study of olaparib in breast cancer patients: biological evaluation from a 'window of opportunity' trial

A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-Negative Breast Cancers

Altered immunolocalization of heat-shock proteins in human peri-implant gingiva

Apatinib for the treatment of gastric cancer

Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?

Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.

CDK4/6 inhibitors in HER2-positive breast cancer

Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

Diagnostic tests based on gene expression profile in breast cancer: from background to clinical use.

Effect of Primary Letrozole Treatment on Tumor Expression of mTOR and HIF-1α and Relation to Clinical Response

Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma

Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery

Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy

HE4 and epithelial ovarian cancer: comparison and clinical evaluation of two immunoassays and a combination algorithm

HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study

Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome

Human kallikrein 5: an interesting novel biomarker in ovarian cancer patients that elicits humoral response

Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues

Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunity.

Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials

Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma

Low-Dose Oral Ethinylestradiol With Concomitant Low-Dose Acetylsalicylic Acid for Advanced Castrate-Resistant Prostate Cancer

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis

Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy ⬇️

Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence

MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities.

Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition

Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?

New molecular therapies in patients with advanced Hepatocellular Cancer in second line of treatment: Is a real defeat?: Results from a literature based meta-analysis of randomized trials

No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell Lung Cancer: A Literature-Based Meta-Analysis of Randomized Trials.

Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials

Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis

Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management

Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer: A meta-analysis of randomized trials

Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients

Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma

Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility.

Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy